BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 801853)

  • 1. [Tumors as allotransplants: neoplastic immunodepression and prospects of immunotherapy].
    Clerici E
    Ann Laringol Otol Rinol Faringol; 1975; 74(1):45-65. PubMed ID: 801853
    [No Abstract]   [Full Text] [Related]  

  • 2. Current aspects of tumor immunology. Preface and introduction.
    Weiss DW
    Isr J Med Sci; 1973 Mar; 9(3):205-16. PubMed ID: 4575649
    [No Abstract]   [Full Text] [Related]  

  • 3. An insight into cancer immunology and immunotherapy.
    Thompson RB
    Prog Clin Pathol; 1975; 6():159-76. PubMed ID: 1105670
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunology and cancer].
    Brunner KT
    Schweiz Med Wochenschr; 1973 Sep; 103(36):1249-52. PubMed ID: 4584090
    [No Abstract]   [Full Text] [Related]  

  • 5. [Problems of tumor immunology and immunotherapy].
    Schmidt CG
    Helv Chir Acta; 1973 Mar; 40(1):77-86. PubMed ID: 4540691
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of immune processes on the growth and regression of malignant tumors].
    Russo V; Russo L
    Vopr Onkol; 1974; 20(6):68-75. PubMed ID: 4603500
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunology and the surgeon.
    Kettlewell M; Steer H; Gill PG; Morris PJ
    Surg Annu; 1979; 11():1-23. PubMed ID: 116377
    [No Abstract]   [Full Text] [Related]  

  • 8. Malignancy as a complication of immunosuppressive therapy.
    Leibowitz S; Schwartz RS
    Adv Intern Med; 1971; 17():95-123. PubMed ID: 4145004
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tumor immunology].
    Cerni CM
    Subsid Med; 1974; 2():21-5. PubMed ID: 4606048
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms of tumor-induced immunological deficiencies and their possible significance in relation to the use of immunopotentiators in tumor-bearing hosts.
    Kerbel RS
    Biomedicine; 1974 Jul; 21(7):253-61. PubMed ID: 4547979
    [No Abstract]   [Full Text] [Related]  

  • 11. Transfer factor in cellular immunity.
    Lawrence HS
    Harvey Lect; 1974; 68():239-350. PubMed ID: 4616018
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor immunology.
    McKhann CF; Yarlott MA
    CA Cancer J Clin; 1975; 25(4):187-97. PubMed ID: 805638
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunology of melanoma].
    Vanwijck R; Bernheim JL; Lejeune FJ
    Acta Chir Belg; 1974 Mar; 73(2):135-88. PubMed ID: 4615541
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunotherapy of neoplasms. Part I - Assumptions (author's transl)].
    Szmigiel Z; Skotnicki AB
    Przegl Lek; 1975; 32(5):460-5. PubMed ID: 50612
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunologic approach to cancer.
    Mitchison NA
    Transplant Proc; 1970 Mar; 2(1):92-103. PubMed ID: 4107297
    [No Abstract]   [Full Text] [Related]  

  • 16. The gordian knot of tumour immunology.
    Amlot P
    Guys Hosp Rep; 1974; 123(1):43-51. PubMed ID: 4549511
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer active immunotherapy. Immunoprophylaxis and immunorestoration. An introduction.
    Mathé G
    Recent Results Cancer Res; 1976; 55():1-402. PubMed ID: 1087040
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuraminidase induced immunospecific destruction of transplantable experimental tumors.
    Sethi KK; Teschner M
    Postepy Hig Med Dosw; 1974; 28(1):103-20. PubMed ID: 4816378
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor immunology.
    Klein G
    Transplant Proc; 1973 Mar; 5(1):31-41. PubMed ID: 4348706
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospects for tumor immunotherapy in man, with emphasis on its use as an adjunct to surgery for primary operable cancer.
    Southam CM
    J Med Liban; 1975; 28(1):43-66. PubMed ID: 1107552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.